18 May 2013
Keywords: gsk, overcomes, augmentin, woes, posts, strong, sales
Article | 05 May 2003
Europe's leading drugmaker, GlaxoSmithKline, has reported results aheadof expectations for the first quarter of 2003, as the firm benefited
from cost-cutting ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 May 2003
17 May 2013
© 2013 thepharmaletter.com